Evolutionary Trajectories to Antibiotic Resistance

Annual Review of Microbiology

Volumn 71, Issue , 2017, Pages 579-596

  Hughes, Diarmaid ^a   Andersson, Dan I ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Coselection; Epistasis; Mutation rates; Population bottlenecks; Relative fitness; Selection pressure

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ALLELE; ANALYTICAL PARAMETERS; ANTIBIOTIC RESISTANCE; ARTICLE; EPISTASIS; ESCHERICHIA COLI; GENE MUTATION; GENETIC HETEROGENEITY; HORIZONTAL GENE TRANSFER; KLEBSIELLA PNEUMONIAE; MUTATION RATE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; BACTERIUM; DRUG EFFECTS; GENETICS; MICROBIAL GENETICS; MOLECULAR BIOLOGY; MOLECULAR EVOLUTION; MUTATION; PROCEDURES; REPRODUCTIVE FITNESS;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, BACTERIAL; EVOLUTION, MOLECULAR; GENETIC FITNESS; GENETICS, MICROBIAL; MOLECULAR BIOLOGY; MUTATION;

EID: 85029325925     PISSN: 00664227     EISSN: 15453251     Source Type: Book Series    
DOI: 10.1146/annurev-micro-090816-093813     Document Type: Article

References (124)

1. Abdulkarim F, Hughes D. 1996. Homologous recombination between the tuf genes of Salmonella typhimurium. J. Mol. Biol. 260:506-22
2. Alekshun MN, Levy SB. 2007. Molecular mechanisms of antibacterial multidrug resistance. Cell 128:1037-50
3. Anderson P, Roth J. 1981. Spontaneous tandem genetic duplications in Salmonella typhimurium arise by unequal recombination between rRNA (rrn) cistrons. PNAS 78:3113-17
4. Andersson DI. 2015. Improving predictions of the risk of resistance development against new and old antibiotics. Clin. Microbiol. Infect. Dis. 21:894-98
5. Andersson DI, Hughes D. 1996. Muller's ratchet decreases fitness of a DNA-based microbe. PNAS 93:906-7
6. Andersson DI, Hughes D. 2010. Antibiotic resistance and its cost: Is it possible to reverse resistance? Nat. Rev. Microbiol. 8:260-71
7. Andersson DI, Hughes D. 2014. Microbiological effects of sublethal levels of antibiotics. Nat. Rev. Microbiol. 12:465-78
8. Andersson DI, Hughes D, Roth JR. 2013. The origin ofmutants under selection: interactions of mutation, growth, and selection. EcoSal Plus 4(2). https://doi.org/10.1128/ecosalplus.5.6.6
9. Andersson DI, Levin BR. 1999. The biological cost of antibiotic resistance. Curr. Opin.Microbiol. 2:489-93
10. Angst DC,Hall AR. 2013. The cost of antibiotic resistance depends on evolutionary history in Escherichia coli. BMC Evol. Biol. 13:163
11. Banerjee R, Johnson JR. 2014. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob. Agents Chemother. 58:4997-5004
12. Banos RC, Vivero A, Aznar S, Garcia J, Pons M, et al. 2009. Differential regulation of horizontally acquired and core genome genes by the bacterial modulator H-NS. PLOS Genet. 5:e1000513
13. Bean DC, Livermore DM, Papa I, Hall LM. 2005. Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man. J. Antimicrob. Chemother. 56:962-64
14. Bedhomme S, Hillung J, Elena SF. 2015. Emerging viruses: why they are not jack of all trades? Curr. Opin. Virol. 10:1-6
15. Bingen E, Lambert-Zechovsky N, Mariani-Kurkdjian P, Doit C, Aujard Y, et al. 1990. Bacterial counts in cerebrospinal fluid of children with meningitis. Eur. J. Clin. Microbiol. Infect. Dis. 9:278-81
16. Bjorkman J, Hughes D, Andersson DI. 1998. Virulence of antibiotic-resistant Salmonella typhimurium. PNAS 95:3949-53
17. Bjorkman J, Samuelsson P, Andersson DI, Hughes D. 1999. Novel ribosomal mutations affecting translational accuracy, antibiotic resistance and virulence of Salmonella typhimurium. Mol. Microbiol. 31:53-58
18. Bottger EC, Springer B, Pletschette M, Sander P. 1998. Fitness of antibiotic-resistant microorganisms and compensatory mutations. Nat. Med. 4:1343-44
19. BrandisG,HughesD. 2013. Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates. J. Antimicrob. Chemother. 68:2493-97
20. Brandis G, Pietsch F, Alemayehu R, Hughes D. 2015. Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis. J. Antimicrob. Chemother. 70:680-85
21. BrandisG,WrandeM,Liljas L, Hughes D. 2012. Fitness-compensatory mutations in rifampicin-resistant RNA polymerase. Mol. Microbiol. 85:142-51
22. Brolund A, Sandegren L. 2016. Characterization of ESBL disseminating plasmids. Infect Dis. 48:18-25
23. Cabezon E, Ripoll-Rozada J, Pena A, de la Cruz F, Arechaga I. 2015. Towards an integrated model of bacterial conjugation. FEMS Microbiol. Rev. 39:81-95
24. Cambray G, Guerout AM, Mazel D. 2010. Integrons. Annu. Rev. Genet. 44:141-66
25. Canetti G. 1956. Dynamic aspects of the pathology and bacteriology of tuberculous lesions. Am. Rev. Tuberc. 74:13-21; discussion, 22-27
26. Canetti G. 1965. Present aspects of bacterial resistance in tuberculosis. Am. Rev. Respir. Dis. 92:687-703
27. Chen L, Mathema B, Chavda KD, DeLeo FR, Bonomo RA, Kreiswirth BN. 2014. Carbapenemaseproducing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol. 22:686-96
28. Chen L, Mathema B, Pitout JD, DeLeo FR, Kreiswirth BN. 2014. Epidemic Klebsiella pneumoniae ST258 is a hybrid strain. mBio 5:e01355-14
29. Chevereau G, Dravecka M, Batur T, Guvenek A, Ayhan DH, et al. 2015. Quantifying the determinants of evolutionary dynamics leading to drug resistance. PLOS Biol. 13:e1002299
30. Clancy CJ, Chen L, Hong JH, Cheng S, Hao B, et al. 2013. Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin. Antimicrob. Agents Chemother. 57:5258-65
31. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, et al. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200
32. Dahlberg C, Chao L. 2003. Amelioration of the cost of conjugative plasmid carriage in Escherichia coli K12. Genetics 165:1641-49
33. D'Costa VM, McGrannKM, Hughes DW,Wright GD. 2006. Sampling the antibiotic resistome. Science 311:374-77
34. de Visser JA, Krug J. 2014. Empirical fitness landscapes and the predictability of evolution. Nat. Rev. Genet. 15:480-90
35. Denamur E, Bonacorsi S, Giraud A, Duriez P, Hilali F, et al. 2002. High frequency of mutator strains among human uropathogenic Escherichia coli isolates. J. Bacteriol. 184:605-9
36. Drake JW. 1999. The distribution of rates of spontaneous mutation over viruses, prokaryotes, and eukaryotes. Ann. N. Y. Acad. Sci. 870:100-7
37. Drake JW, Charlesworth B, Charlesworth D, Crow JF. 1998. Rates of spontaneous mutation. Genetics 148:1667-86
38. Dunny G, Yuhasz M, EhrenfeldE. 1982. Genetic and physiological analysis of conjugation in Streptococcus faecalis. J. Bacteriol. 151:855-59
39. Enne VI, Livermore DM, Stephens P, Hall LM. 2001. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 357:1325-8
40. FeldmanWE. 1976. Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis. J. Pediatr. 88:549-52
41. Foster PL. 2006. Methods for determining spontaneous mutation rates. Methods Enzymol. 409:195-213
42. Garcia LG, Lemaire S, Kahl BC, Becker K, Proctor RA, et al. 2013. Antibiotic activity against smallcolony variants of Staphylococcus aureus: review of in vitro, animal and clinical data. J. Antimicrob. Chemother. 68:1455-64
43. Gerrish PJ, Lenski RE. 1998. The fate of competing beneficial mutations in an asexual population. Genetica 102-103:127-44
44. Gifford DR, MacLean RC. 2013. Evolutionary reversals of antibiotic resistance in experimental populations of Pseudomonas aeruginosa. Evolution 67:2973-81
45. Gorini L. 1970. Informational suppression. Annu. Rev. Genet. 4:107-34
46. Gullberg E, Albrecht LM, Karlsson C, Sandegren L, Andersson DI. 2014. Selection of a multidrug resistance plasmid by sublethal levels of antibiotics and heavy metals. mBio 5:e01918-14
47. Gullberg E, Cao S, Berg OG, Ilback C, Sandegren L, et al. 2011. Selection of resistant bacteria at very low antibiotic concentrations. PLOS Pathog. 7:e1002158
48. GwynnMN, Portnoy A, Rittenhouse SF, Payne DJ. 2010. Challenges of antibacterial discovery revisited. Ann. N. Y. Acad. Sci. 1213:5-19
49. Hall AR, MacLean RC. 2011. Epistasis buffers the fitness effects of rifampicin-resistance mutations in Pseudomonas aeruginosa. Evolution 65:2370-79
50. Hilty M, Betsch BY, Bogli-Stuber K, Heiniger N, Stadler M, et al. 2012. Transmission dynamics of extended-spectrum ?-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin. Infect. Dis. 55:967-75
51. Hughes D, Andersson DI. 2015. Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms. Nat. Rev. Genet. 16:459-71
52. Hughes D, Andersson DI. 2017. Environmental and genetic modulation of the phenotypic expression of antibiotic resistance. FEMS Microbiol. Rev. 41:374-91
53. Hughes JM, Lohman BK, Deckert GE, Nichols EP, Settles M, et al. 2012. The role of clonal interference in the evolutionary dynamics of plasmid-host adaptation. mBio 3:e00077-12
54. Huseby DL, Pietsch F, Brandis G, Garoff L, Tegehall A, Hughes D. 2017. Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli. Mol. Biol. Evol. 34:1029-39
55. Imamovic L, SommerMO. 2013. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci. Transl. Med. 5:204ra132
56. Johanson U, Aevarsson A, Liljas A, Hughes D. 1996. The dynamic structure of EF-G studied by fusidic acid resistance and internal revertants. J. Mol. Biol. 258:420-32
57. Johnson JR, Miller S, Johnston B, Clabots C, Debroy C. 2009. Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and urovirulent E. coli strains among dogs and cats within a household. J. Clin. Microbiol. 47:3721-25
58. Johnson JR, Tchesnokova V, Johnston B, Clabots C, Roberts PL, et al. 2013. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J. Infect. Dis. 207:919-28
59. Kim S, Lieberman TD, Kishony R. 2014. Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance. PNAS 111:14494-99
60. Komp Lindgren P, Marcusson LL, Sandvang D, Frimodt-Moller N, Hughes D. 2005. Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. Antimicrob. Agents Chemother. 49:2343-51
61. Kondrashov DA, Kondrashov FA. 2015. Topological features of rugged fitness landscapes in sequence space. Trends Genet. 31:24-33
62. Kubicek-Sutherland JZ, Heithoff DM, Ersoy SC, Shimp WR, House JK, et al. 2015. Host-dependent induction of transient antibiotic resistance: a prelude to treatment failure. EBioMedicine 2:1169-78
63. Lannergard J, Cao S, Norstrom T, Delgado A, Gustafson JE, Hughes D. 2011. Genetic complexity of fusidic acid-resistant small colony variants (SCV) in Staphylococcus aureus. PLOS ONE 6:e28366
64. Lazar V, Nagy I, Spohn R, Csorgo B, Gyorkei A, et al. 2014. Genome-wide analysis captures the determinants of the antibiotic cross-resistance interaction network. Nat. Commun. 5:4352
65. LeClerc JE, Li B, Payne WL, Cebula TA. 1996. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274:1208-11
66. Lee Y, Kim BS, Chun J, Yong JH, Lee YS, et al. 2014. Clonality and resistome analysis of KPCproducing Klebsiella pneumoniae strain isolated in Korea using whole genome sequencing. Biomed. Res. Int. 2014:352862
67. Leekitcharoenphon P,Hendriksen RS, Le Hello S, Weill FX, Baggesen DL, et al. 2016. Global genomic epidemiology of Salmonella enterica serovar Typhimurium DT104. Appl. Environ. Microbiol. 82:2516-26
68. Locke JB, HilgersM, ShawKJ. 2009. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Antimicrob.AgentsChemother. 53:5265-74
69. Loftie-Eaton W, Yano H, Burleigh S, Simmons RS, Hughes JM, et al. 2016. Evolutionary paths that expand plasmid host-range: implications for spread of antibiotic resistance. Mol. Biol. Evol. 33:885-97
70. Lofton H, Pranting M, Thulin E, Andersson DI. 2013. Mechanisms and fitness costs of resistance to antimicrobial peptides LL-37, CNY100HL and wheat germ histones. PLOS ONE 8:e68875
71. Lynch M. 2010. Evolution of the mutation rate. Trends Genet. 26:345-52
72. Macvanin M, Hughes D. 2005. Hyper-susceptibility of a fusidic acid-resistant mutant of Salmonella to different classes of antibiotics. FEMS Microbiol. Lett. 247:215-20
73. Maisnier-Patin S, Berg OG, Liljas L, Andersson DI. 2002. Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimurium. Mol. Microbiol. 46:355-66
74. Marcusson LL, Frimodt-Moller N, Hughes D. 2009. Interplay in the selection of fluoroquinolone resistance and bacterial fitness. PLOS Pathog. 5:e1000541
75. Mariam SH,Werngren J, Aronsson J, Hoffner S, Andersson DI. 2011. Dynamics of antibiotic resistant Mycobacterium tuberculosis during long-term infection and antibiotic treatment. PLOS ONE 6:e21147
76. Markussen T, Marvig RL, Gomez-Lozano M, Aanaes K, Burleigh AE, et al. 2014. Environmental heterogeneity drives within-host diversification and evolution of Pseudomonas aeruginosa. mBio 5:e01592-14
77. Mathers AJ, Peirano G, Pitout JD. 2015. Escherichia coli ST131: the quintessential example of an international multiresistant high-risk clone. Adv. Appl. Microbiol. 90:109-54
78. Mathers AJ, Peirano G, Pitout JD. 2015. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin. Microbiol. Rev. 28:565-91
79. Molton JS,Tambyah PA, Ang BS,LingML, Fisher DA. 2013. The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia. Clin. Infect. Dis. 56:1310-18
80. Nagaev I, Bjorkman J, Andersson DI, Hughes D. 2001. Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol. Microbiol. 40:433-39
81. Nicolas-ChanoineMH, Blanco J, Leflon-Guibout V, Demarty R, AlonsoMP, et al. 2008. Intercontinental emergence of Escherichia coli clone O25: H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-81
82. Nilsson AI, Berg OG, Aspevall O, Kahlmeter G, Andersson DI. 2003. Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob. Agents Chemother. 47:2850-58
83. NishinoK,Hayashi-NishinoM,Yamaguchi A. 2009.H-NSmodulates multidrug resistance of Salmonella enterica serovar Typhimurium by repressing multidrug efflux genes acrEF. Antimicrob. Agents Chemother. 53:3541-43
84. Oethinger M, KernWV, Jellen-Ritter AS, McMurry LM, Levy SB. 2000. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob. Agents Chemother. 44:10-13
85. Oliver A, CantonR,CampoP, Baquero F, Blazquez J. 2000. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:1251-54
86. Oliver A, Mulet X, Lopez-Causape C, Juan C. 2015. The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist. Updates 21-22:41-59
87. O'Neill AJ, Huovinen T, Fishwick CW, Chopra I. 2006. Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob. Agents Chemother. 50:298-309
88. Oz T, Guvenek A, Yildiz S, Karaboga E, Tamer YT, et al. 2014. Strength of selection pressure is an important parameter contributing to the complexity of antibiotic resistance evolution. Mol. Biol. Evol. 31:2387-401
89. Palaci M, Dietze R, Hadad DJ, Ribeiro FK, Peres RL, et al. 2007. Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis. J. Clin. Microbiol. 45:4064-66
90. Palmer AC, Kishony R. 2013. Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance. Nat. Rev. Genet. 14:243-48
91. Pawlowski AC, Wang W, Koteva K, Barton HA, McArthur AG, Wright GD. 2016. A diverse intrinsic antibiotic resistome from a cave bacterium. Nat. Commun. 7:13803
92. Pena-Miller R, Laehnemann D, Jansen G, Fuentes-Hernandez A, Rosenstiel P, et al. 2013. When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transition. PLOS Biol. 11:e1001540
93. Perichon B, Courvalin P. 2006. Synergism between ?-lactams and glycopeptides against VanA-type methicillin-resistant Staphylococcus aureus and heterologous expression of the vanA operon. Antimicrob. Agents Chemother. 50:3622-30
94. Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, et al. 2013. The epidemic of extended-spectrum-?-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. mBio 4:e00377-13
95. Reams AB, Kofoid E, Kugelberg E, Roth JR. 2012. Multiple pathways of duplication formation with and without recombination (RecA) in Salmonella enterica. Genetics 192:397-415
96. Reams AB, Kofoid E, Savageau M, Roth JR. 2010. Duplication frequency in a population of Salmonella enterica rapidly approaches steady state with or without recombination. Genetics 184:1077-94
97. Roberts AP, Mullany P. 2011. Tn916-like genetic elements: a diverse group of modular mobile elements conferring antibiotic resistance. FEMS Microbiol. Rev. 35:856-71
98. Roth JR. 1981. Frameshift suppression. Cell 24:601-2
99. Rozen DE, McGee L, Levin BR, Klugman KP. 2007. Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 51:412-16
100. Salverda ML, Dellus E, Gorter FA, Debets AJ, van der Oost J, et al. 2011. Initial mutations direct alternative pathways of protein evolution. PLOS Genet. 7:e1001321
101. SanMillan A, HeilbronK,MacLeanRC. 2014. Positive epistasis between co-infecting plasmids promotes plasmid survival in bacterial populations. ISME J. 8:601-12
102. SanMillan A, Pena-Miller R, Toll-RieraM,Halbert ZV, McLean AR, et al. 2014. Positive selection and compensatory adaptation interact to stabilize non-transmissible plasmids. Nat. Commun. 5:5208
103. Sander P, Springer B, PrammanananT, Sturmfels A, Kappler M, et al. 2002. Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob. Agents Chemother. 46:1204-11
104. Schrag SJ, Perrot V, Levin BR. 1997. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc. Biol. Sci. 264:1287-91
105. Shcherbakov D, Akbergenov R, Matt T, Sander P, Andersson DI, Bottger EC. 2010. Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in-vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis. Mol. Microbiol. 77:830-40
106. Silva RF, Mendonca SC, Carvalho LM, Reis AM, Gordo I, et al. 2011. Pervasive sign epistasis between conjugative plasmids and drug-resistance chromosomal mutations. PLOS Genet. 7:e1002181
107. Silver LL. 2011. Challenges of antibacterial discovery. Clin. Microbiol. Rev. 24:71-109
108. Smith MR, Wood WB Jr. 1956. An experimental analysis of the curative action of penicillin in acute bacterial infections: III. The effect of suppuration upon the antibacterial action of the drug. J. Exp. Med. 103:509-22
109. Sommer MO, Dantas G, Church GM. 2009. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 325:1128-31
110. Stephan J, Mailaender C, Etienne G, Daffe M, Niederweis M. 2004. Multidrug resistance of a porin deletion mutant of Mycobacterium smegmatis. Antimicrob. Agents Chemother. 48:4163-70
111. Suerbaum S, Josenhans C. 2007. Helicobacter pylori evolution and phenotypic diversification in a changing host. Nat. Rev. Microbiol. 5:441-52
112. Sundqvist M, Geli P, Andersson DI, Sjolund-Karlsson M, Runehagen A, et al. 2009. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J. Antimicrob. Chemother. 65:350-60
113. Szybalski W, Bryson V. 1952. Genetic studies on microbial cross resistance to toxic agents: I. Cross resistance of Escherichia coli to fifteen antibiotics. J. Bacteriol. 64:489-99
114. Thulin E, SundqvistM, Andersson DI. 2015. Amdinocillin (mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli. Antimicrob. Agents Chemother. 59:1718-27
115. Trindade S, Sousa A, Xavier KB, Dionisio F, Ferreira MG, Gordo I. 2009. Positive epistasis drives the acquisition of multidrug resistance. PLOS Genet. 5:e1000578
116. Tubulekas I, Buckingham RH, Hughes D. 1991. Mutant ribosomes can generate dominant kirromycin resistance. J. Bacteriol. 173:3635-43
117. Villa J, Viedma E, Branas P,Mingorance J, Chaves F. 2014. Draft whole-genome sequence of OXA-48-producing multidrug-resistant Klebsiella pneumoniae KP-ST11-OXA-48. Genome Announc. 2: e00737-14
118. Villa L, Capone A, Fortini D, Dolejska M, Rodriguez I, et al. 2013. Reversion to susceptibility of a carbapenem-resistant clinical isolate of Klebsiella pneumoniae producingKPC-3. J. Antimicrob. Chemother. 68:2482-86
119. Vogwill T, Kojadinovic M, MacLean RC. 2016. Epistasis between antibiotic resistance mutations and genetic background shape the fitness effect of resistance across species of Pseudomonas. Proc. Biol. Sci. 283:20160151
120. Vogwill T, MacLean RC. 2015. The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach. Evol. Appl. 8:284-95
121. Weinreich DM, Delaney NF, DepristoMA, Hartl DL. 2006. Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312:111-14
122. WiserMJ, Ribeck N, Lenski RE. 2013. Long-term dynamics of adaptation in asexual populations. Science 342:1364-67
123. Worby CJ, Lipsitch M, Hanage WP. 2014. Within-host bacterial diversity hinders accurate reconstruction of transmission networks from genomic distance data. PLOS Comput. Biol. 10:e1003549
124. zurWiesch PA, Kouyos R, Engelstadter J, Regoes RR, Bonhoeffer S. 2011. Population biological principles of drug-resistance evolution in infectious diseases. Lancet Infect. Dis. 11:236-47